Diabetic Kidney Disease
140
22
35
55
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
20 trials with published results (14%)
Research Maturity
55 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.3%
13 terminated out of 140 trials
80.9%
-5.7% vs benchmark
17%
24 trials in Phase 3/4
36%
20 of 55 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 55 completed trials
Clinical Trials (140)
Real World Evidence Clinical Utility Study of KidneyIntelX
Decision Impact Trial of KidneyIntelX
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
Prospective Decision Impact Trial of KidneyIntelX
Mechanisms of Diabetic Kidney Disease in American Indians
Uric Acid Lowering Trial in Youth Onset T2D
Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis
Evaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized Trial
Dosimetry of Tc-99m-Tilmanocept
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidney Disease in Type 2 Diabetes
The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.
Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
Mechanism of SGLT2 Inhibition in the Kidney
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Renal Mechanism of SGLT2 Inhibition
Atrasentan in Patients With Proteinuric Glomerular Diseases
Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)